RELMADA THERAPEUTICS, INC. - Common stock, $0.001 par value per share (RLMD)

CUSIP: 75955J402

Q3 2021 13F Holders as of 30 Sep 2021

Holder snapshot 7 signals
Share change
+82,825
Put/Call ratio
19%
SEC-reported price per share
$26.21
Number of holders
81
Value change
-$4,620,967
Number of buys
47
Open additional details 1 more signal available
Number of sells
25
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
105,000,000

Security key

75955J402

Report period

Q3 2021

Institutions

81

Top holders

10

Ownership snapshot

Top reported holders of RLMD - RELMADA THERAPEUTICS, INC. - Common stock, $0.001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
RTW INVESTMENTS, LP
Disclosed value leader
RTW INVESTMENTS, LP
Comparable rows
0/15
Latest evidence
30 Jun 2021
13F Highest disclosed value: $49,232,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

RTW INVESTMENTS, LP has the largest disclosed position value at $49.23M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens RTW INVESTMENTS, LP's linked filing trail.
Disclosed position value Top 5
RTW INVESTMENTS, LP $49.23M
BlackRock Finance, Inc. $47.06M
Venrock Adviser, LLC $44.42M
Avoro Capital Advisors LLC $29.93M
VANGUARD GROUP INC $24.7M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
RTW INVESTMENTS, LP
13F
Company
13F
—
denominator unverified
$49,232,000
1,538,026 shares
— 30 Jun 2021
BlackRock Finance, Inc.
13F
Company
13F
—
denominator unverified
$47,058,000
1,470,107 shares
— 30 Jun 2021
Venrock Adviser, LLC
13F
Company
13F
—
denominator unverified
$44,421,000
1,387,720 shares
— 30 Jun 2021
Avoro Capital Advisors LLC
13F
Company
13F
—
denominator unverified
$29,929,000
935,000 shares
— 30 Jun 2021
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$24,705,000
771,776 shares
— 30 Jun 2021
PARSONS CAPITAL MANAGEMENT INC/RI
13F
Company
13F
—
denominator unverified
$14,418,000
450,412 shares
— 30 Jun 2021
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2021

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
81
Shares
10,023,314
Rows available
81
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2021 vs Q2 2021 Across Filers

Q2 2021 holders
83
Q3 2021 holders
81
Holder diff
-2
Investor Q2 2021 Shares Q3 2021 Shares Share Diff Share Chg % Q2 2021 value Q3 2021 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .